Corning and SGD Pharma formed JV in June 2023 to expand pharmaceutical manufacturing in India
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
No post-injection Delirium/Sedation Syndrome (PDSS) observed through 56 weeks
All drug substance for Moderna’s authorized Spikevax (COVID-19 mRNA vaccine) targeting the SARS-CoV-2 LP.8.1 variant is produced at the company’s facility in Laval, Quebec
Importantly, the combination of giredestrant and everolimus was well tolerated
Subscribe To Our Newsletter & Stay Updated